Search

Contributor:

and Esther Kim, MD

St<strike>ep</strike>upid Edits in a Neovascular AMD Patient

Stepupid Edits in a Neovascular AMD Patient

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Switching From Bevacizumab to Aflibercept 8 mg in a Patient With Neovascular AMD

Switching From Bevacizumab to Aflibercept 8 mg in a Patient With Neovascular AMD

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Neovascular AMD (PCV Variant) Patient Switched to Two Different Next-generation Therapies

Neovascular AMD (PCV Variant) Patient Switched to Two Different Next-generation Therapies

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Switching from Bevacizumab to Aflibercept 8 mg in a Neovascular AMD Patient After Handoff from a Colleague

Switching from Bevacizumab to Aflibercept 8 mg in a Neovascular AMD Patient After Handoff from a Colleague

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Conversion to Neovascular AMD in a Geographic Atrophy Patient With a 2-Year Treatment History

Conversion to Neovascular AMD in a Geographic Atrophy Patient With a 2-Year Treatment History

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Switching From Aflibercept 2 mg to Faricimab in a Patient With Newly Diagnosed Neovascular AMD and Worsening Pigment Epithelium Detachment

Switching From Aflibercept 2 mg to Faricimab in a Patient With Newly Diagnosed Neovascular AMD and Worsening Pigment Epithelium Detachment

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

The Business of Retina at VBS

The Business of Retina at VBS

Esther L. Kim, MD and Basil K. Williams Jr, MD

AI in Retina: Yay or Nay?

AI in Retina: Yay or Nay?

Matthew R. Starr, MD, and Esther L. Kim, MD

Wet AMD and Next-Generation Therapies

David Miller, MD; Esther Kim, MD; and Ehsan Rahimy, MD

DME, DR, and Next-Generation Therapies

David Miller, MD; Esther Kim, MD; and Ehsan Rahimy, MD

Treating Geographic Atrophy (GA) In Your Practice

Esther Kim, MD; John W. Kitchens, MD; and Scott Walter, MD

Diagnosing Geographic Atrophy (GA) and Identifying Eligible Patients For Therapy

Esther Kim, MD; John W. Kitchens, MD; and Scott Walter, MD

GA Options in Clinical Therapy: Why Aren't Doctors Embracing Complement Inhibition?

John Kitchens, MD, Miguel Busquets, MD, and Esther Kim, MD